Medical Resource Site

Medical Resource Site

  • Novo Nordisk Medical
  • Search Medical Information
  • Prescribing Information
  • evidenceFinder
  • Safety Data Sheets
  • Submit a Question

Prescribing Information


If the Prescribing Information you're looking for is not shown, please Submit a Question.


Activella® (estradiol/norethindrone acetate) tablets

Fiasp® (insulin aspart injection)

GlucaGen® (glucagon [rDNA origin] for injection)

Levemir® (insulin detemir [rDNA origin] injection)

Norditropin® (somatropin [rDNA] injection)

Novoeight® (Antihemophilic Factor [Recombinant], rFVIII)

Novolin® 70/30 (70% NPH, human insulin isophane suspension and 30% regular, human insulin injection [recombinant DNA origin])

Novolin® N (NPH, human insulin isophane suspension [recombinant DNA origin])

Novolin® R (regular, human insulin injection [recombinant DNA origin])

NovoLog® (insulin aspart injection)

NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection)

NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Ozempic® (semaglutide) injection

PrandiMet® (repaglinide and metformin HCl)

Prandin® (repaglinide)

Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated

Ryzodeg® 70/30 (insulin degludec and insulin aspart injection)

Saxenda® (liraglutide injection)

Tresiba® (insulin degludec injection)

Tretten® (Coagulation Factor XIII A-Subunit (Recombinant))

Vagifem® (estradiol vaginal tablets)

Victoza® (liraglutide injection)

Xultophy® 100/3.6 (insulin degludec 100 units/mL and liraglutide 3.6 mg/mL injection)


Novo Nordisk®

Novo Nordisk is a registered trademark of Novo Nordisk A/S.

  • Legal Notice
  • Privacy Policy
  • Contact Us
  • novonordisk-us.com
© 2017 Novo Nordisk All rights reserved.